English

Lightlake Therapeutics Inc.

EDGAR

LLTP Quarterly report (10-Q) · filed 2022-11-14

111 filing records in this dataset, filed from 2007-03-13 to 2022-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

174 thousand USD

2022-09-30 · USD

Exact inputs and evidence

Revenue: 173874 USD Source

Operating margin

-5,538.37%

2022-09-30 · %

Exact inputs and evidence

Operating Income: -9629784 USD Source
Revenue: 173874 USD Source

Operating cash flow

-4.74 million USD

2022-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -17468878 USD Source
Operating Cash Flow: -12728578 USD Source

Free cash flow

-5.15 million USD

2022-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -17468878 USD Source
Operating Cash Flow: -12728578 USD Source
Capital Expenditure: 418962 USD Source
Capital Expenditure: 7881 USD Source

Cash and cash equivalents: 35.4 million USD 2022-09-30 Source
Exact value

35400000 USD
Long-term debt including current maturities: 12.3 million USD 2022-09-30 Source
Exact value

12324237 USD
Shares outstanding: 5.16 million shares 2022-09-30 Source
Exact value

5164951 shares

Reported share-count change

11.84% · 547 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

4618221 shares · 2021-09-30· Source
5164951 shares · 2022-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

22.3 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Revenue: 47785478 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 33985255 USD · 2021-01-01 – 2021-09-30 Source
Revenue: 4470009 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 3894275 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 173874 USD · 2022-07-01 – 2022-09-30 Source

Operating cash flow

-15.5 million USD

2021-10-01 – 2022-09-30

Exact inputs and evidence

Operating cash flow: 1926489 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -77064 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -2103256 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -12728578 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -2103256 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -17468878 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -12728578 USD · 2022-01-01 – 2022-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-11-14.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2021-12-31
Operating income: 11 of 11 periods available· newest 2021-12-31
Net income: 11 of 11 periods available· newest 2021-12-31
Operating cash flow: 10 of 11 periods available· newest 2021-12-31
Capital expenditure: 7 of 11 periods available· newest 2021-12-31
Total assets: 9 of 11 periods available· newest 2021-12-31
Total liabilities: 9 of 11 periods available· newest 2021-12-31
Current assets: 9 of 11 periods available· newest 2021-12-31
Current liabilities: 9 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2021-12-31
Shares outstanding: 9 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+61.3%

Prior period

USD 29.63 million

2020-01-01 – 2020-12-31
Current period

USD 47.79 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

47785478 − 29625181 = 18160297 USD

29625181 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
47785478 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Year-over-year change in Revenue: 18160297 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 47785478 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#806018 Filing: 000138550822000038 Input fundies:Revenue: 29625181 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#807035 Filing: 000138550822000038
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.87 million

Prior period

−USD 1.86 million

2020-01-01 – 2020-12-31
Current period

USD 3.01 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

3008790 − -1861449 = 4870239 USD

-1861449 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
3008790 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Year-over-year change in Net income: 4870239 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 3008790 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1100881 Filing: 000138550822000038 Input fundies:NetIncome: -1861449 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1101996 Filing: 000138550822000038
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.96 million

Prior period

−USD 2.03 million

2020-01-01 – 2020-12-31
Current period

USD 1.93 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

1926489 − -2028773 = 3955262 USD

-2028773 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
1926489 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Year-over-year change in Operating cash flow: 3955262 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 1926489 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1008709 Filing: 000138550822000038 Input fundies:OperatingCashFlow: -2028773 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1009759 Filing: 000138550822000038
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 50,887

2020-01-01 – 2020-12-31
Current period

USD 0

2021-01-01 – 2021-12-31

Exact inputs and evidence

0 − 50887 = -50887 USD

50887 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
0 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Year-over-year change in Capital expenditure: -50887 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1014226 Filing: 000138550822000038 Input fundies:CapitalExpenditure: 50887 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1015214 Filing: 000138550822000038
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2021-01-01 – 2021-12-31

Revenue USD 47.79 million 100% of revenue
Operating costs Derived USD 42.63 million 89% of revenue
Operating income USD 5.16 million 11% of revenue
Tax, interest and other Derived USD 2.15 million 4.5% of revenue
Net income USD 3.01 million 6.3% of revenue

Cash

Operating cash flow USD 1.93 million 4% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived USD 1.93 million 4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Not shown: operating income or net income is not reported.
2015 Operating loss: operating costs were 545% of revenue.
2016 Operating loss: operating costs were 178% of revenue.
2017 36%62%
2018 Operating loss: operating costs were 112% of revenue.
2019 Operating loss: operating costs were 252% of revenue.
2021 Operating loss: operating costs were 108% of revenue.
2022 89%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2013-08-01 – 2014-07-31	0	11303369 Derived	-11303369	179449 Derived	-11482818	Unavailable	Source 2013-08-01 – 2014-07-31: 0 USD Inspect Revenue Open source 2013-08-01 – 2014-07-31: -11303369 USD Inspect Operating Income Open source 2013-08-01 – 2014-07-31: -11482818 USD Inspect Net Income Open source 2013-08-01 – 2014-07-31: -1005323 USD Inspect Operating Cash Flow Open source
2015 2014-08-01 – 2015-07-31	1550000	8449493 Derived	-6899493	138380 Derived	-7037873	-4239083 Derived	Source 2014-08-01 – 2015-07-31: 1550000 USD Inspect Revenue Open source 2014-08-01 – 2015-07-31: -6899493 USD Inspect Operating Income Open source 2014-08-01 – 2015-07-31: -7037873 USD Inspect Net Income Open source 2014-08-01 – 2015-07-31: -4239083 USD Inspect Operating Cash Flow Open source 2014-08-01 – 2015-07-31: 0 USD Inspect Capital Expenditure Open source
2016 2015-08-01 – 2016-07-31	9897595	17636074 Derived	-7738479	75777 Derived	-7814256	-922824 Derived	Source 2015-08-01 – 2016-07-31: 9897595 USD Inspect Revenue Open source 2015-08-01 – 2016-07-31: -7738479 USD Inspect Operating Income Open source 2015-08-01 – 2016-07-31: -7814256 USD Inspect Net Income Open source 2015-08-01 – 2016-07-31: -915287 USD Inspect Operating Cash Flow Open source 2015-08-01 – 2016-07-31: 7537 USD Inspect Capital Expenditure Open source
2017 2016-08-01 – 2017-07-31	18445996	11353231 Derived	7092765	512152 Derived	6580613	5556162 Derived	Source 2016-08-01 – 2017-07-31: 18445996 USD Inspect Revenue Open source 2016-08-01 – 2017-07-31: 7092765 USD Inspect Operating Income Open source 2016-08-01 – 2017-07-31: 6580613 USD Inspect Net Income Open source 2016-08-01 – 2017-07-31: 5556162 USD Inspect Operating Cash Flow Open source 2016-08-01 – 2017-07-31: 0 USD Inspect Capital Expenditure Open source
2018 2017-01-01 – 2017-12-31	15552000	17429000 Derived	-1877000	729000 Derived	-2606000	Unavailable	Source 2017-01-01 – 2017-12-31: 15552000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -1877000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -2606000 USD Inspect Net Income Open source
2019 2018-01-01 – 2018-12-31	13982177	35172617 Derived	-21190440	4876 Derived	-21195316	-522972 Derived	Source 2018-01-01 – 2018-12-31: 13982177 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -21190440 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -21195316 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -522972 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source
2021 2020-01-01 – 2020-12-31	29625181	31866198 Derived	-2241017	-379568 Derived	-1861449	-2079660 Derived	Source 2020-01-01 – 2020-12-31: 29625181 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -2241017 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -1861449 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -2028773 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 50887 USD Inspect Capital Expenditure Open source
2022 2021-01-01 – 2021-12-31	47785478	42629167 Derived	5156311	2147521 Derived	3008790	1926489 Derived	Source 2021-01-01 – 2021-12-31: 47785478 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 5156311 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 3008790 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 1926489 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 47.8M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-07-31	Revenue	0	Revenue: 0 Open source
20142014-07-31	Revenue	0	Revenue: 0 Open source
20152015-07-31	Revenue	1550000	Revenue: 1550000 Open source
20162016-07-31	Revenue	9897595	Revenue: 9897595 Open source
20172017-07-31	Revenue	18445996	Revenue: 18445996 Open source
20182017-12-31	Revenue	15552000	Revenue: 15552000 Open source
20192018-12-31	Revenue	13982177	Revenue: 13982177 Open source
20212020-12-31	Revenue	29625181	Revenue: 29625181 Open source
20222021-12-31	Revenue	47785478	Revenue: 47785478 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

61.3% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122012-07-31	Year over year	No prior comparable period	Revenue: 0 Open source
20142014-07-31	Year over year	No prior comparable period	Revenue: 0 Open source
20152015-07-31	Year over year	No prior comparable period	Revenue: 1550000 Open source Revenue: 0 Open source
20162016-07-31	Year over year	538.6%	Revenue: 9897595 Open source Revenue: 1550000 Open source
20172017-07-31	Year over year	86.4%	Revenue: 18445996 Open source Revenue: 9897595 Open source
20182017-12-31	Year over year	No prior comparable period	Revenue: 15552000 Open source
20192018-12-31	Year over year	-10.1%	Revenue: 13982177 Open source Revenue: 15552000 Open source
20212020-12-31	Year over year	No prior comparable period	Revenue: 29625181 Open source
20222021-12-31	Year over year	61.3%	Revenue: 47785478 Open source Revenue: 29625181 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 10.8% 2022

Net margin 6.3% 2022

Free cash flow margin 4% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20122012-07-31	Operating margin	Not reported	Operating Income: -12335706 Open source Revenue: 0 Open source
20142014-07-31	Operating margin	Not reported	Operating Income: -11303369 Open source Revenue: 0 Open source
20152015-07-31	Operating margin	-445.1%	Operating Income: -6899493 Open source Revenue: 1550000 Open source
20162016-07-31	Operating margin	-78.2%	Operating Income: -7738479 Open source Revenue: 9897595 Open source
20172017-07-31	Operating margin	38.5%	Operating Income: 7092765 Open source Revenue: 18445996 Open source
20182017-12-31	Operating margin	-12.1%	Operating Income: -1877000 Open source Revenue: 15552000 Open source
20192018-12-31	Operating margin	-151.6%	Operating Income: -21190440 Open source Revenue: 13982177 Open source
20212020-12-31	Operating margin	-7.6%	Operating Income: -2241017 Open source Revenue: 29625181 Open source
20222021-12-31	Operating margin	10.8%	Operating Income: 5156311 Open source Revenue: 47785478 Open source
20122012-07-31	Net margin	Not reported	Net Income: -12421188 Open source Revenue: 0 Open source
20142014-07-31	Net margin	Not reported	Net Income: -11482818 Open source Revenue: 0 Open source
20152015-07-31	Net margin	-454.1%	Net Income: -7037873 Open source Revenue: 1550000 Open source
20162016-07-31	Net margin	-79%	Net Income: -7814256 Open source Revenue: 9897595 Open source
20172017-07-31	Net margin	35.7%	Net Income: 6580613 Open source Revenue: 18445996 Open source
20182017-12-31	Net margin	-16.8%	Net Income: -2606000 Open source Revenue: 15552000 Open source
20192018-12-31	Net margin	-151.6%	Net Income: -21195316 Open source Revenue: 13982177 Open source
20212020-12-31	Net margin	-6.3%	Net Income: -1861449 Open source Revenue: 29625181 Open source
20222021-12-31	Net margin	6.3%	Net Income: 3008790 Open source Revenue: 47785478 Open source
20122012-07-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20142014-07-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1005323 Open source
20152015-07-31	Free cash flow margin	-273.5%	Revenue: 1550000 Open source Operating Cash Flow: -4239083 Open source Capital Expenditure: 0 Open source
20162016-07-31	Free cash flow margin	-9.3%	Revenue: 9897595 Open source Operating Cash Flow: -915287 Open source Capital Expenditure: 7537 Open source
20172017-07-31	Free cash flow margin	30.1%	Revenue: 18445996 Open source Operating Cash Flow: 5556162 Open source Capital Expenditure: 0 Open source
20182017-12-31	Free cash flow margin	Not reported	Revenue: 15552000 Open source
20192018-12-31	Free cash flow margin	-3.7%	Revenue: 13982177 Open source Operating Cash Flow: -522972 Open source Capital Expenditure: 0 Open source
20212020-12-31	Free cash flow margin	-7%	Revenue: 29625181 Open source Operating Cash Flow: -2028773 Open source Capital Expenditure: 50887 Open source
20222021-12-31	Free cash flow margin	4%	Revenue: 47785478 Open source Operating Cash Flow: 1926489 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.9M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-07-31	Operating cash flow	Not reported	No source recorded
20142014-07-31	Operating cash flow	-1005323	Operating Cash Flow: -1005323 Open source
20152015-07-31	Operating cash flow	-4239083	Operating Cash Flow: -4239083 Open source
20162016-07-31	Operating cash flow	-915287	Operating Cash Flow: -915287 Open source
20172017-07-31	Operating cash flow	5556162	Operating Cash Flow: 5556162 Open source
20182017-12-31	Operating cash flow	Not reported	No source recorded
20192018-12-31	Operating cash flow	-522972	Operating Cash Flow: -522972 Open source
20212020-12-31	Operating cash flow	-2028773	Operating Cash Flow: -2028773 Open source
20222021-12-31	Operating cash flow	1926489	Operating Cash Flow: 1926489 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1.9M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-07-31	Free cash flow	Unavailable	No source recorded
20142014-07-31	Free cash flow	Unavailable	Operating Cash Flow: -1005323 Open source
20152015-07-31	Free cash flow	-4239083	Operating Cash Flow: -4239083 Open source Capital Expenditure: 0 Open source
20162016-07-31	Free cash flow	-922824	Operating Cash Flow: -915287 Open source Capital Expenditure: 7537 Open source
20172017-07-31	Free cash flow	5556162	Operating Cash Flow: 5556162 Open source Capital Expenditure: 0 Open source
20182017-12-31	Free cash flow	Unavailable	No source recorded
20192018-12-31	Free cash flow	-522972	Operating Cash Flow: -522972 Open source Capital Expenditure: 0 Open source
20212020-12-31	Free cash flow	-2079660	Operating Cash Flow: -2028773 Open source Capital Expenditure: 50887 Open source
20222021-12-31	Free cash flow	1926489	Operating Cash Flow: 1926489 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

33.5% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20122012-07-31	Liabilities / assets	1,475.7%	Total Liabilities: 663694 Open source Total Assets: 44976 Open source
20142014-07-31	Liabilities / assets	1,123.8%	Total Liabilities: 3378725 Open source Total Assets: 300657 Open source
20152015-07-31	Liabilities / assets	1,819.3%	Total Liabilities: 8874520 Open source Total Assets: 487795 Open source
20162016-07-31	Liabilities / assets	350%	Total Liabilities: 6586834 Open source Total Assets: 1881878 Open source
20172017-07-31	Liabilities / assets	59.9%	Total Liabilities: 6473476 Open source Total Assets: 10807885 Open source
20182017-12-31	Liabilities / assets	37.4%	Total Liabilities: 7772998 Open source Total Assets: 20773250 Open source
20192018-12-31	Liabilities / assets	42.6%	Total Liabilities: 12527058 Open source Total Assets: 29386324 Open source
20212020-12-31	Liabilities / assets	41.4%	Total Liabilities: 25120790 Open source Total Assets: 60613032 Open source
20222021-12-31	Liabilities / assets	33.5%	Total Liabilities: 23587990 Open source Total Assets: 70427798 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

10.1× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20122012-07-31	Current assets / current liabilities	0.03×	Current Assets: 20423 Open source Current Liabilities: 663694 Open source
20142014-07-31	Current assets / current liabilities	0.14×	Current Assets: 278849 Open source Current Liabilities: 1967255 Open source
20152015-07-31	Current assets / current liabilities	0.13×	Current Assets: 467360 Open source Current Liabilities: 3574520 Open source
20162016-07-31	Current assets / current liabilities	0.44×	Current Assets: 1856295 Open source Current Liabilities: 4236834 Open source
20172017-07-31	Current assets / current liabilities	2.59×	Current Assets: 10787442 Open source Current Liabilities: 4166949 Open source
20182017-12-31	Current assets / current liabilities	3.67×	Current Assets: 20754949 Open source Current Liabilities: 5657193 Open source
20192018-12-31	Current assets / current liabilities	2.99×	Current Assets: 29370578 Open source Current Liabilities: 9827058 Open source
20212020-12-31	Current assets / current liabilities	9.21×	Current Assets: 59099153 Open source Current Liabilities: 6420244 Open source
20222021-12-31	Current assets / current liabilities	10.1×	Current Assets: 69158964 Open source Current Liabilities: 6845558 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2012-08-01 – 2013-07-31	−USD 9.18 million Exact value Exact value: -9177491 USD 2012-08-01 – 2013-07-31: -9177491 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2013-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -9177491 USD Concept: fundies:NetIncome Period: 2012-08-01 to 2013-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2013-07-31&surface=latest&period_type=duration&start=2012-08-01&unit=USD&dimensions= Input fundies:NetIncome: -9177491 USD (2012-08-01 to 2013-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420414063064/lltp-20140731.xml#65387 Filing: 000114420414063064 The citation records this snapshot. The page link may show a newer release later.	−USD 747,300 Exact value Exact value: -747300 USD 2012-08-01 – 2013-07-31: -747300 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2013-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: -747300 USD Concept: fundies:OperatingCashFlow Period: 2012-08-01 to 2013-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2013-07-31&surface=latest&period_type=duration&start=2012-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -747300 USD (2012-08-01 to 2013-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420414063064/lltp-20140731.xml#85461 Filing: 000114420414063064 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-08-01 – 2014-07-31	−USD 11.48 million Exact value Exact value: -11482818 USD 2013-08-01 – 2014-07-31: -11482818 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2014-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -11482818 USD Concept: fundies:NetIncome Period: 2013-08-01 to 2014-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2014-07-31&surface=latest&period_type=duration&start=2013-08-01&unit=USD&dimensions= Input fundies:NetIncome: -11482818 USD (2013-08-01 to 2014-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416092544/opnt-20160131.xml#752354 Filing: 000114420416092544 The citation records this snapshot. The page link may show a newer release later.	−USD 1.01 million Exact value Exact value: -1005323 USD 2013-08-01 – 2014-07-31: -1005323 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2014-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: -1005323 USD Concept: fundies:OperatingCashFlow Period: 2013-08-01 to 2014-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2014-07-31&surface=latest&period_type=duration&start=2013-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1005323 USD (2013-08-01 to 2014-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416092544/opnt-20160131.xml#777983 Filing: 000114420416092544 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-08-01 – 2015-07-31	−USD 7.04 million Exact value Exact value: -7037873 USD 2014-08-01 – 2015-07-31: -7037873 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2015-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -7037873 USD Concept: fundies:NetIncome Period: 2014-08-01 to 2015-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2015-07-31&surface=latest&period_type=duration&start=2014-08-01&unit=USD&dimensions= Input fundies:NetIncome: -7037873 USD (2014-08-01 to 2015-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416130283/opnt-20160731.xml#101542 Filing: 000114420416130283 The citation records this snapshot. The page link may show a newer release later.	−USD 4.24 million Exact value Exact value: -4239083 USD 2014-08-01 – 2015-07-31: -4239083 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2015-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: -4239083 USD Concept: fundies:OperatingCashFlow Period: 2014-08-01 to 2015-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2015-07-31&surface=latest&period_type=duration&start=2014-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4239083 USD (2014-08-01 to 2015-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416130283/opnt-20160731.xml#113434 Filing: 000114420416130283 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2014-08-01 – 2015-07-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2015-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2014-08-01 to 2015-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2015-07-31&surface=latest&period_type=duration&start=2014-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2014-08-01 to 2015-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416130283/opnt-20160731.xml#117189 Filing: 000114420416130283 The citation records this snapshot. The page link may show a newer release later.	−USD 4.24 million Calculation and evidence -4239083 − 0 USD Exact free cash flow: -4239083 USD 2014-08-01 – 2015-07-31: -4239083 USD · Inspect Operating Cash Flow · Source 2014-08-01 – 2015-07-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2015-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: -4239083 USD Concept: free-cash-flow Period: 2014-08-01 to 2015-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4239083 USD (2014-08-01 to 2015-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416130283/opnt-20160731.xml#113434 Filing: 000114420416130283 Input fundies:CapitalExpenditure: 0 USD (2014-08-01 to 2015-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420416130283/opnt-20160731.xml#117189 Filing: 000114420416130283 The citation records this snapshot. The page link may show a newer release later.
2016 2015-08-01 – 2016-07-31	−USD 7.81 million Exact value Exact value: -7814256 USD 2015-08-01 – 2016-07-31: -7814256 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2016-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -7814256 USD Concept: fundies:NetIncome Period: 2015-08-01 to 2016-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2016-07-31&surface=latest&period_type=duration&start=2015-08-01&unit=USD&dimensions= Input fundies:NetIncome: -7814256 USD (2015-08-01 to 2016-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#122170 Filing: 000114420417052467 The citation records this snapshot. The page link may show a newer release later.	−USD 915,287 Exact value Exact value: -915287 USD 2015-08-01 – 2016-07-31: -915287 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2016-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: -915287 USD Concept: fundies:OperatingCashFlow Period: 2015-08-01 to 2016-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2016-07-31&surface=latest&period_type=duration&start=2015-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -915287 USD (2015-08-01 to 2016-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#126793 Filing: 000114420417052467 The citation records this snapshot. The page link may show a newer release later.	USD 7,537 Exact value Exact value: 7537 USD 2015-08-01 – 2016-07-31: 7537 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2016-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 7537 USD Concept: fundies:CapitalExpenditure Period: 2015-08-01 to 2016-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2016-07-31&surface=latest&period_type=duration&start=2015-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7537 USD (2015-08-01 to 2016-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#131256 Filing: 000114420417052467 The citation records this snapshot. The page link may show a newer release later.	−USD 922,824 Calculation and evidence -915287 − 7537 USD Exact free cash flow: -922824 USD 2015-08-01 – 2016-07-31: -915287 USD · Inspect Operating Cash Flow · Source 2015-08-01 – 2016-07-31: 7537 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2016-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: -922824 USD Concept: free-cash-flow Period: 2015-08-01 to 2016-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -915287 USD (2015-08-01 to 2016-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#126793 Filing: 000114420417052467 Input fundies:CapitalExpenditure: 7537 USD (2015-08-01 to 2016-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#131256 Filing: 000114420417052467 The citation records this snapshot. The page link may show a newer release later.
2017 2016-08-01 – 2017-07-31	USD 6.58 million Exact value Exact value: 6580613 USD 2016-08-01 – 2017-07-31: 6580613 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2017-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: 6580613 USD Concept: fundies:NetIncome Period: 2016-08-01 to 2017-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2017-07-31&surface=latest&period_type=duration&start=2016-08-01&unit=USD&dimensions= Input fundies:NetIncome: 6580613 USD (2016-08-01 to 2017-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550819000028/opnt-20181231.xml#287662 Filing: 000138550819000028 The citation records this snapshot. The page link may show a newer release later.	USD 5.56 million Exact value Exact value: 5556162 USD 2016-08-01 – 2017-07-31: 5556162 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2017-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: 5556162 USD Concept: fundies:OperatingCashFlow Period: 2016-08-01 to 2017-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2017-07-31&surface=latest&period_type=duration&start=2016-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5556162 USD (2016-08-01 to 2017-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550819000028/opnt-20181231.xml#286547 Filing: 000138550819000028 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2016-08-01 – 2017-07-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2017-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2016-08-01 to 2017-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2017-07-31&surface=latest&period_type=duration&start=2016-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2016-08-01 to 2017-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#131066 Filing: 000114420417052467 The citation records this snapshot. The page link may show a newer release later.	USD 5.56 million Calculation and evidence 5556162 − 0 USD Exact free cash flow: 5556162 USD 2016-08-01 – 2017-07-31: 5556162 USD · Inspect Operating Cash Flow · Source 2016-08-01 – 2017-07-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2017-07-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: 5556162 USD Concept: free-cash-flow Period: 2016-08-01 to 2017-07-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5556162 USD (2016-08-01 to 2017-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550819000028/opnt-20181231.xml#286547 Filing: 000138550819000028 Input fundies:CapitalExpenditure: 0 USD (2016-08-01 to 2017-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000114420417052467/opnt-20170731.xml#131066 Filing: 000114420417052467 The citation records this snapshot. The page link may show a newer release later.
2018 2017-01-01 – 2017-12-31	−USD 2.61 million Exact value Exact value: -2606000 USD 2017-01-01 – 2017-12-31: -2606000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2017-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -2606000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2606000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550819000028/opnt-20181231.xml#287133 Filing: 000138550819000028 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2019 2018-01-01 – 2018-12-31	−USD 21.2 million Exact value Exact value: -21195316 USD 2018-01-01 – 2018-12-31: -21195316 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2018-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -21195316 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21195316 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550820000039/opnt-20191231.xml#210294 Filing: 000138550820000039 The citation records this snapshot. The page link may show a newer release later.	−USD 522,972 Exact value Exact value: -522972 USD 2018-01-01 – 2018-12-31: -522972 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2018-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: -522972 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -522972 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550820000039/opnt-20191231.xml#209878 Filing: 000138550820000039 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2018-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550820000039/opnt-20191231.xml#216770 Filing: 000138550820000039 The citation records this snapshot. The page link may show a newer release later.	−USD 522,972 Calculation and evidence -522972 − 0 USD Exact free cash flow: -522972 USD 2018-01-01 – 2018-12-31: -522972 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2018-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: -522972 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -522972 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550820000039/opnt-20191231.xml#209878 Filing: 000138550820000039 Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550820000039/opnt-20191231.xml#216770 Filing: 000138550820000039 The citation records this snapshot. The page link may show a newer release later.
2020 2019-01-01 – 2019-12-31	USD 11.59 million Exact value Exact value: 11593050 USD 2019-01-01 – 2019-12-31: 11593050 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2019-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: 11593050 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 11593050 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550821000035/opnt-20201231.htm#1135298 Filing: 000138550821000035 The citation records this snapshot. The page link may show a newer release later.	USD 4.06 million Exact value Exact value: 4063890 USD 2019-01-01 – 2019-12-31: 4063890 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2019-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: 4063890 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4063890 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550821000035/opnt-20201231.htm#1048343 Filing: 000138550821000035 The citation records this snapshot. The page link may show a newer release later.	USD 302,475 Exact value Exact value: 302475 USD 2019-01-01 – 2019-12-31: 302475 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2019-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 302475 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 302475 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550821000035/opnt-20201231.htm#1051432 Filing: 000138550821000035 The citation records this snapshot. The page link may show a newer release later.	USD 3.76 million Calculation and evidence 4063890 − 302475 USD Exact free cash flow: 3761415 USD 2019-01-01 – 2019-12-31: 4063890 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 302475 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2019-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: 3761415 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4063890 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550821000035/opnt-20201231.htm#1048343 Filing: 000138550821000035 Input fundies:CapitalExpenditure: 302475 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550821000035/opnt-20201231.htm#1051432 Filing: 000138550821000035 The citation records this snapshot. The page link may show a newer release later.
2021 2020-01-01 – 2020-12-31	−USD 1.86 million Exact value Exact value: -1861449 USD 2020-01-01 – 2020-12-31: -1861449 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2020-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: -1861449 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1861449 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1101996 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.	−USD 2.03 million Exact value Exact value: -2028773 USD 2020-01-01 – 2020-12-31: -2028773 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2020-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: -2028773 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2028773 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1009759 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.	USD 50,887 Exact value Exact value: 50887 USD 2020-01-01 – 2020-12-31: 50887 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2020-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 50887 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50887 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1015214 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.	−USD 2.08 million Calculation and evidence -2028773 − 50887 USD Exact free cash flow: -2079660 USD 2020-01-01 – 2020-12-31: -2028773 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 50887 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2020-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: -2079660 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2028773 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1009759 Filing: 000138550822000038 Input fundies:CapitalExpenditure: 50887 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1015214 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.
2022 2021-01-01 – 2021-12-31	USD 3.01 million Exact value Exact value: 3008790 USD 2021-01-01 – 2021-12-31: 3008790 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Net Income: 3008790 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3008790 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1100881 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.	USD 1.93 million Exact value Exact value: 1926489 USD 2021-01-01 – 2021-12-31: 1926489 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Operating Cash Flow: 1926489 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1926489 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1008709 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2021-01-01 – 2021-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1014226 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.	USD 1.93 million Calculation and evidence 1926489 − 0 USD Exact free cash flow: 1926489 USD 2021-01-01 – 2021-12-31: 1926489 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lightlake Therapeutics Inc. · 2021-12-31 Lightlake Therapeutics Inc. (edgar:1385508) Free cash flow: 1926489 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385508?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1926489 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1008709 Filing: 000138550822000038 Input fundies:CapitalExpenditure: 0 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385508/000138550822000038/opnt-20211231.htm#1014226 Filing: 000138550822000038 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

111 filings · 3,084 latest values · 3,084 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001385508, 1385508, LLTP, OPNT, edgar:1385508

Also known as Lightlake Therapeutics Inc., Madrona Ventures, Inc., OPIANT PHARMACEUTICALS, INC., Opiant Pharmaceuticals, Inc.

Lightlake Therapeutics Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation